Loading clinical trials...
Loading clinical trials...
A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat
Conditions
Interventions
lesinurad
lesinurad
+1 more
Locations
72
United States
Birmingham, Alabama, United States
Tempe, Arizona, United States
Glendale, California, United States
Huntington Beach, California, United States
Irvine, California, United States
San Diego, California, United States
Start Date
March 1, 2013
Primary Completion Date
August 9, 2016
Completion Date
October 6, 2016
Last Updated
January 30, 2018
NCT07089875
NCT07116746
NCT03047369
NCT07002762
NCT07310849
NCT05665699
Lead Sponsor
Ardea Biosciences, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions